PRF Technologies Ltd. (PRFX) vs Virax Biolabs Group Limited (VRAX)
A side-by-side comparison of PRF Technologies Ltd. and Virax Biolabs Group Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PRFX
PRF Technologies Ltd.
$0.88HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VRAX
Virax Biolabs Group Limited
$2.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PRFX vs VRAX
growth of $100 · dividends reinvested · last 4yPRFX -99.6% (-75.0%/yr)VRAX -99.9% (-84.8%/yr)PRFX compounded faster over this window
Log scale — wide-divergence pair
PRFX VRAX
PRFX vs VRAX: by the numbers
- •VRAX is the larger company ($378849 vs $70884 market cap).
- •Both run net losses; PRFX's is the smaller (-22521.52% vs -40439.10% net margin).
Metrics side by side
Valuation
| Metric | PRFX | VRAX |
|---|---|---|
| P/S ratio | 1.79 | N/A |
| P/B ratio | 0.00 | 0.05 |
Profitability
| Metric | PRFX | VRAX |
|---|---|---|
| Gross margin | -4864.71% | 61.90% |
| Operating margin | -29335.29% | -51515.17% |
| Net margin | -22521.52% | -40439.10% |
| ROE | -56.04% | -66.30% |
| ROIC | -53.95% | -83.46% |
Growth (annualized)
| Metric | PRFX | VRAX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -36.87% |
| Total return CAGR (5Y) | -74.50% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.